![]() |
市場調查報告書
商品編碼
2128241
全髖置換術市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測。Hip Replacement Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
受骨關節炎盛行率上升、老年人口增加以及先進整形外科植入日益普及的推動,全球髖關節置換市場正經歷穩定成長。報告顯示,2025年全球髖置換術市場規模為84億美元,預計將從2026年的88億美元成長至2034年的137.6億美元,預測期內複合年成長率(CAGR)為5.75%。北美地區引領全球市場,預計到2025年將佔據34.46%的市場佔有率,這主要得益於該地區較高的髖置換術量、有利的保險報銷政策以及持續的產品創新。
全髖置換術是一種廣泛應用的整形外科手術,透過以人工植入取代受損的髖關節,以緩解疼痛、恢復活動能力並提高生活品質。此手術主要建議用於患有嚴重骨關節炎、髖部骨折、類風濕性關節炎以及其他影響日常生活能力的退化性關節疾病的患者。
市場定義和範圍
在全髖關節置換術中,受損的髖關節部分會被金屬、陶瓷或聚乙烯製成的植入所取代。根據患者的具體情況和關節損傷程度,該手術可能包括全髖關節置換術、部分髖關節置換術、重新置換和表面置換術。
該市場涵蓋髖關節植入、機器人輔助手術系統、個人化假體、導航技術以及醫院、門診手術中心 (ASC)、整形外科診所和專科醫療機構使用的整形外科手術服務。由於機器人手術、3D 列印和患者客製化植入等技術的不斷進步,全球髖置換術市場正在擴張。
市場動態
促進因素
骨關節炎盛行率的不斷上升仍然是市場成長的主要驅動力。隨著全球人口老化,罹患退化性關節疾病的風險增加,需要全髖置換術的患者族群也隨之擴大。加之人們對現有治療方案的認知不斷提高以及診斷率的提升,全球手術量還在進一步成長。
另一個主要的成長要素是患者客製化人工髖植入和機器人輔助手術的日益普及。製造商正積極利用3D列印和電腦輔助導航等先進技術來開發患者客製化植入,以提高手術精度、植入耐用性和復健效果。
趨勢
影響市場格局的關鍵趨勢之一是數位醫療工具和機器人輔助髖關節置換術的日益普及。醫院和醫療機構正在採用先進的機器人平台和導航系統,以提高手術精度並改善患者預後。
另一個新興趨勢是擴大使用線上患者教育平台和行動應用程式來支持患者術前和術後復健。這些數位資源有助於患者參與治療、術後復健以及全髖置換術的長期恢復。
阻礙因素
儘管市場成長強勁,但與整形外科植入相關的召回和訴訟仍然是重大挑戰。由於醫療設備故障、植入磨損、感染疾病、過敏反應和金屬相關併發症等問題,針對主要製造商的多起訴訟已經出現,影響了市場信心。
此外,嚴格的監管要求和產品召回可能會增加合規成本,並可能延遲新植入技術進入市場。
新冠疫情的影響
2020年,新冠疫情導致擇期和非緊急整形外科手術延期,對髖關節置換市場造成了負面影響。醫院優先處理急診病例,導致手術量和植入需求暫時下降。然而,隨著封鎖限制的逐步解除,在積壓手術和患者需求增加的推動下,市場在2021年及之後幾年強勁復甦。
就手術類型而言,預計到2026年,「全髖置換術術」將佔據73.86%的市場佔有率,成為推動市場成長的主要因素。這主要得益於全球全髖關節置換術手術數量的增加以及機器人輔助手術的日益普及。 「部分髖置換術術」和「重新置換」也呈現穩定成長的態勢,這主要歸因於骨關節炎盛行率的上升以及對重新置換植入需求的增加。
按最終用戶分類,「醫院和門診手術中心(ASC)」細分市場預計在2026年將佔市場佔有率的72.96%。這一成長主要得益於手術數量的增加、有利的保險報銷政策以及先進機器人技術的快速普及。此外,由於尋求關節疾病治療和專業整形外科護理的患者人數不斷增加,整形外科診所預計也將顯著成長。
北美在全球髖關節置換市場中處於領先地位,預計到 2025 年將達到 29 億美元,到 2026 年將達到 30.4 億美元。該地區受益於有利的報銷政策、大量的手術、先進的醫療基礎設施以及機器人輔助整形外科手術的持續創新。
歐洲是第二大區域市場,預計2025年將達21.8億美元,2026年將達22.7億美元。這一成長主要得益於髖關節置換術數量的增加、完善的保險報銷機制以及對個性化植入日益成長的需求。亞太地區預計將成為成長最快的地區,這主要得益於中國、日本和印度醫療基礎設施的不斷完善、老年人口的成長以及人們對先進整形外科治療的認知度不斷提高。拉丁美洲以及中東和非洲地區也呈現溫和成長,這得益於醫療服務可近性的提高、整形外科疾病盛行率的上升以及人工髖關節的普及。
報告範圍
本報告對全球髖關節置換市場進行了全面分析,涵蓋2025年、2026年和2034年的市場規模、主要成長要素、新興趨勢、阻礙因素、新冠疫情的影響、按手術類型和最終用戶分類的市場細分、區域洞察、競爭格局、報銷政策、法規環境以及近期行業發展動態。報告還評估了塑造整形外科產業未來的技術創新,包括機器人手術的進步和個人化植入的開發。
The global hip replacement market is experiencing steady growth due to the rising prevalence of osteoarthritis, increasing geriatric population, and growing adoption of technologically advanced orthopedic implants. According to the report, the global hip replacement market size was valued at USD 8.40 billion in 2025 and is projected to grow from USD 8.80 billion in 2026 to USD 13.76 billion by 2034, exhibiting a CAGR of 5.75% during the forecast period. North America dominated the global market with a 34.46% market share in 2025, supported by a high volume of hip arthroplasty procedures, favorable reimbursement policies, and continuous product innovation.
Hip replacement surgery is a widely performed orthopedic procedure in which damaged hip joints are replaced with artificial implants to relieve pain, restore mobility, and improve quality of life. The procedure is primarily recommended for patients suffering from severe osteoarthritis, hip fractures, rheumatoid arthritis, and other degenerative joint disorders that limit daily activities.
Market Definition and Scope
Hip replacement involves replacing damaged portions of the hip joint with artificial prosthetic implants made from metal, ceramic, or polyethylene materials. The procedure includes total hip replacement, partial hip replacement, revision surgery, and hip resurfacing, depending on the patient's medical condition and severity of joint damage.
The market covers hip implants, robotic-assisted surgical systems, customized prostheses, navigation technologies, and orthopedic surgical services used across hospitals, ambulatory surgery centers (ASCs), orthopedic clinics, and specialty healthcare facilities. Continuous technological advancements, including robotic surgery, 3D printing, and patient-specific implants, are expanding the scope of the global hip replacement market.
Market Dynamics
Drivers
The increasing prevalence of osteoarthritis remains the primary factor driving market growth. Aging populations worldwide are more susceptible to degenerative joint diseases, creating a large patient pool requiring hip replacement procedures. Rising awareness regarding available treatment options and improved diagnosis rates are further increasing the number of surgeries performed globally.
Another major growth driver is the growing adoption of customized hip implants and robotic-assisted surgical procedures. Manufacturers are increasingly utilizing advanced technologies such as 3D printing and computer-assisted navigation to develop patient-specific implants that improve surgical precision, implant longevity, and recovery outcomes.
Trends
A significant trend shaping the market is the increasing use of digital healthcare tools and robotic-assisted hip replacement surgery. Hospitals and healthcare providers are adopting advanced robotic platforms and navigation systems to enhance surgical accuracy and improve patient outcomes.
Another emerging trend is the growing availability of online patient education platforms and mobile applications that support patients before and after surgery. These digital resources improve patient engagement, rehabilitation, and long-term recovery following hip replacement procedures.
Restraints
Despite strong market growth, product recalls and lawsuits associated with orthopedic implants remain major challenges. Device failures, implant wear, infections, allergic reactions, and metal-related complications have resulted in several legal cases against major manufacturers, affecting market confidence.
Additionally, stringent regulatory requirements and product recalls increase compliance costs and may delay the introduction of new implant technologies into the market.
Impact of COVID-19
The COVID-19 pandemic negatively affected the hip replacement market during 2020 due to the postponement of elective and non-emergency orthopedic surgeries. Hospitals prioritized emergency care, leading to a temporary decline in procedural volumes and implant demand. However, following the easing of lockdown restrictions, the backlog of delayed surgeries and increasing patient demand contributed to strong market recovery during 2021 and subsequent years.
By procedure, the Total Hip Replacement segment is expected to dominate the market with a 73.86% share in 2026, driven by the increasing number of total hip arthroplasty procedures worldwide and growing adoption of robotic-assisted surgery. Partial hip replacement and revision procedures are also witnessing steady growth due to rising osteoarthritis prevalence and increasing demand for revision implants.
By end-user, the Hospitals & Ambulatory Surgery Centers (ASCs) segment is projected to account for 72.96% of the market in 2026. Growth is supported by increasing surgical volumes, favorable reimbursement policies, and rapid adoption of advanced robotic technologies. Orthopedic clinics are also expected to register significant growth due to increasing patient visits for joint disorders and specialized orthopedic care.
North America dominated the global hip replacement market with a valuation of USD 2.90 billion in 2025, which is projected to reach USD 3.04 billion in 2026. The region benefits from favorable reimbursement policies, high surgical volumes, advanced healthcare infrastructure, and continuous innovation in robotic-assisted orthopedic procedures.
Europe represents the second-largest regional market, valued at USD 2.18 billion in 2025 and projected to reach USD 2.27 billion in 2026, driven by increasing hip replacement procedures, strong reimbursement systems, and growing demand for customized implants. Asia Pacific is expected to witness the fastest growth due to expanding healthcare infrastructure, increasing elderly population, and growing awareness of advanced orthopedic treatments across China, Japan, and India. Latin America and the Middle East & Africa are also experiencing gradual growth supported by improving healthcare access, increasing orthopedic disease prevalence, and rising adoption of hip implants.
Competitive Landscape
The global hip replacement market is highly competitive, with leading manufacturers focusing on technological innovation, robotic-assisted surgery, customized implant development, and strategic collaborations to strengthen their market positions. Companies continue investing heavily in research and development to introduce advanced orthopedic implant systems and improve surgical outcomes.
Major companies operating in the market include Zimmer Biomet, Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.), Smith+Nephew, Stryker, Exactech Inc., Gruppo Bioimpianti s.r.l., Conformis, MicroPort Scientific Corporation, and B. Braun SE.
Report Coverage
This report provides a comprehensive analysis of the global hip replacement market, covering market size for 2025, 2026, and 2034, key growth drivers, emerging trends, restraints, COVID-19 impact, segmentation by procedure and end-user, regional insights, competitive landscape, reimbursement policies, regulatory environment, and recent industry developments. The report also evaluates technological innovations, robotic surgery advancements, and customized implant developments shaping the future of the orthopedic industry.
Conclusion
The global hip replacement market is projected to grow from USD 8.40 billion in 2025 to USD 13.76 billion by 2034, driven by the increasing prevalence of osteoarthritis, rising geriatric population, expanding adoption of robotic-assisted surgery, and continuous innovation in customized orthopedic implants. Although product recalls and regulatory challenges remain concerns, favorable reimbursement policies, technological advancements, and growing patient awareness will continue to support long-term market growth across developed and emerging healthcare markets.
Segmentation By Procedure
By End-user
By Geography